Specifically, we found that EGF-induced chemotaxis, a pivotal event for RCC metastasis, was significantly (p < 0.01) impaired in G3BP1 knockdown cells when compared to controls as indicated by micro-Boyden chamber assays (Fig. 2e). The gene discussed is EGF; the disease is renal cell carcinoma.